Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

56
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
56
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

50
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
50
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

75
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
75
Tumor Progression02:07

Tumor Progression

6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structure-property behavior of composites fabricated from waste cotton/polyester fabrics and their potential application in the furniture industry.

International journal of biological macromolecules·2025
Same author

The role of ferroptosis in breast cancer: Tumor progression, immune microenvironment interactions and therapeutic interventions.

European journal of pharmacology·2025
Same author

Nanoparticles as a Novel Platform for Cardiovascular Disease Diagnosis and Therapy.

International journal of nanomedicine·2024
Same author

Preliminary response to Tislelizumab plus chemotherapy drugs in patient with periampullary carcinoma: a report of one case and a literature review.

Frontiers in immunology·2024
Same author

The genus Anemarrhena Bunge: A review on ethnopharmacology, phytochemistry and pharmacology.

Journal of ethnopharmacology·2014
Same author

Myocardial steatosis and its association with obesity and regional ventricular dysfunction: evaluated by magnetic resonance tagging and 1H spectroscopy in healthy African Americans.

International journal of cardiology·2014

Related Experiment Video

Updated: May 16, 2025

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

10.2K

Pancreatic Cancer: Pathogenesis and Clinical Studies.

Kexun Zhou1, Yingping Liu2, Chuanyun Tang3

  • 1Department of Medical Oncology Cancer Center West China Hospital Sichuan University Chengdu China.

Medcomm
|April 4, 2025
PubMed
Summary
This summary is machine-generated.

Pancreatic cancer (PDAC) remains a lethal disease with limited treatment options. This review details current and emerging therapies, highlighting challenges and future directions for more effective pancreatic cancer treatment.

Keywords:
gene alterationpancreatic ductal adenocarcinomapersonalized managementsignaling pathwaystreatment development

More Related Videos

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer
06:20

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on: October 4, 2022

2.5K
Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
06:21

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

10.9K

Related Experiment Videos

Last Updated: May 16, 2025

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

10.2K
Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer
06:20

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on: October 4, 2022

2.5K
Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
06:21

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

10.9K

Area of Science:

  • Oncology
  • Cancer Therapeutics
  • Translational Medicine

Background:

  • Pancreatic cancer (PC), particularly pancreatic ductal adenocarcinoma (PDAC), is a highly lethal malignancy with late diagnosis and resistance to therapies.
  • Key genetic mutations (KRAS, TP53, CDKN2A, SMAD4) and signaling pathways (KRAS-MAPK, PI3K-AKT, TGF-β) are implicated in PDAC pathogenesis.
  • Despite advances, effective therapeutic strategies for PC remain limited, necessitating novel approaches.

Purpose of the Study:

  • To comprehensively review current and emerging treatment modalities for pancreatic cancer (PC).
  • To emphasize the mechanisms, limitations, and potential solutions for existing and novel PC therapies.
  • To provide insights into future directions for developing more effective PC treatment strategies, focusing on PDAC.

Main Methods:

  • Literature review of established and emerging pancreatic cancer (PC) therapies.
  • Analysis of treatment mechanisms, current limitations, and proposed solutions.
  • Synthesis of recent advancements and critical challenges in PC treatment.

Main Results:

  • Current PC therapies including chemotherapy, targeted therapy, immunotherapy, and radiotherapy face significant challenges.
  • Emerging therapies like antibody-drug conjugates (ADCs), CAR-T cells, oncolytic viruses (OVs), cancer vaccines, and bispecific antibodies (BsAbs) show promise but require further development.
  • Understanding of PC pathogenesis provides a basis for targeted therapeutic development, yet clinical efficacy is often limited.

Conclusions:

  • There is an urgent need to address unmet needs in pancreatic cancer (PC) therapy.
  • Overcoming treatment bottlenecks requires innovative strategies and a deeper understanding of PC biology.
  • Future research should focus on integrating advancements and addressing critical challenges to improve outcomes for PDAC patients.